Hologic - HOLX Stock Forecast, Price & News

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Hologic in the last twelve months. There are currently 7 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HOLX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HOLX, but not buy additional shares or sell existing shares.
View HOLX analyst ratings or view top-rated stocks.

13 Wall Street research analysts have issued 12-month price targets for Hologic's stock. Their HOLX share price forecasts range from $70.00 to $90.00. On average, they expect the company's share price to reach $79.83 in the next twelve months. This suggests that the stock has a possible downside of 3.6%.
View analysts price targets for HOLX or view top-rated stocks among Wall Street analysts.

Hologic's stock was trading at $74.81 on January 1st, 2023. Since then, HOLX shares have increased by 10.7% and is now trading at $82.79.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 1st 2023.
View our HOLX earnings forecast.

Hologic will be holding an earnings conference call on Wednesday, February 1st at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

Hologic, Inc. (NASDAQ:HOLX) issued its quarterly earnings data on Monday, October, 31st. The medical equipment provider reported $0.82 EPS for the quarter, topping the consensus estimate of $0.62 by $0.20. The medical equipment provider earned $953.30 million during the quarter, compared to the consensus estimate of $861.68 million. Hologic had a trailing twelve-month return on equity of 31.85% and a net margin of 26.77%. The business's quarterly revenue was down 27.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.61 EPS.
Read the conference call transcript.

Hologic issued an update on its first quarter 2023 earnings guidance on Monday, January, 9th. The company provided EPS guidance of $0.90- for the period, compared to the consensus earnings per share estimate of $0.86. The company issued revenue guidance of $1.07 billion-$1.07 billion, compared to the consensus revenue estimate of $966.37 million.

447 employees have rated Hologic Chief Executive Officer Steve MacMillan on Glassdoor.com. Steve MacMillan has an approval rating of 79% among the company's employees. 81.0% of employees surveyed would recommend working at Hologic to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Hologic investors own include AbbVie (ABBV), NVIDIA (NVDA), Johnson & Johnson (JNJ), Alibaba Group (BABA), Walt Disney (DIS), PayPal (PYPL), Advanced Micro Devices (AMD), CVS Health (CVS), Pfizer (PFE) and Abbott Laboratories (ABT).

Hologic trades on the NASDAQ under the ticker symbol "HOLX."

Hologic's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Allspring Global Investments Holdings LLC (0.43%), Stephens Investment Management Group LLC (0.29%), Wedge Capital Management L L P NC (0.21%), State of Alaska Department of Revenue (0.09%), Boston Common Asset Management LLC (0.09%) and Trinity Street Asset Management LLP (0.08%). Insiders that own company stock include Benjamin Jordan Cohn, Jan Verstreken, John M Griffin, Karleen Marie Oberton, Kevin R Thornal, Peter J Valenti III, Sally Crawford, Sean S Daugherty, Sean S Daugherty and Stephen P Macmillan.
View institutional ownership trends.

Shares of HOLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of HOLX stock can currently be purchased for approximately $82.79.

Hologic (NASDAQ:HOLX) has a market capitalization of $20.41 billion and generates $4.86 billion in revenue each year. The medical equipment provider earns $1.30 billion in net income (profit) each year or $5.12 on an earnings per share basis.

The company employs 6,944 workers across the globe.

Hologic's mailing address is 250 CAMPUS DRIVE, MARLBOROUGH MA, 01752. The official website for the company is www.hologic.com. The medical equipment provider can be reached via phone at (508) 263-2900, via email at michael.watts@hologic.com, or via fax at 781-890-8031.